Assessment of medication for opioid use disorder as delivered within the Vermont hub and spoke system
- PMID: 30577904
- DOI: 10.1016/j.jsat.2018.11.003
Assessment of medication for opioid use disorder as delivered within the Vermont hub and spoke system
Abstract
Opioid overdose deaths in the United States have risen dramatically in the past decade. In response to this public health crisis, Vermont created an innovative system called the "hub-and-spoke" (H & S) system, initiated in January 2013. The H & S system has 7 regional "hubs" that offer methadone and buprenorphine, as well as intensive support, and 77 local "spokes" (primary care settings) that offer buprenorphine (and naltrexone to a much lesser extent). Questionnaires were administered to 80 participants in the H & S system (stratified by geographic region, treatment site, and gender) and 20 participants with opioid use disorder not currently in treatment. Data included demographics, drug and alcohol use; opioid use; injection use; education/employment; criminal justice involvement; family and relationship functioning; health and healthcare utilization; multiple areas of mental health functioning; opioid overdose; satisfaction with life areas; stigma; and perceived treatment effectiveness. In-treatment group participants reported use and functioning for the 90 days prior to the date of the interview (T2) and, retrospectively, a comparable 90-day period prior to treatment entry (T1). Out-of-treatment group participants were queried about functioning at the time of the interview (T2) and 12 months earlier (T1). Individuals not in treatment showed no meaningful changes in any domain from T1 to T2. Conversely, participants currently in treatment in the H & S system showed large reductions in substance use, overdoses, emergency department visits, police contacts, and family conflict, and improvements in mood and satisfaction with all areas of life, except work/school participation. Additionally, 85% of in-treatment participants reported 90-day abstinence from opioid use compared to 0% of out-of-treatment participants at T2. These findings illustrate that medication for opioid use disorders, as delivered in the H & S system in Vermont, is highly effective for reducing opioid use and overdose and improving functioning in many life domains.
Keywords: Hub and spoke; Medication for opioid use disorders; Opioid use disorder; System of care.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system.Prev Med. 2019 Nov;128:105785. doi: 10.1016/j.ypmed.2019.105785. Epub 2019 Jul 27. Prev Med. 2019. PMID: 31362002 Free PMC article.
-
Vermont responds to its opioid crisis.Prev Med. 2015 Nov;80:10-1. doi: 10.1016/j.ypmed.2015.04.002. Epub 2015 Apr 11. Prev Med. 2015. PMID: 25869219
-
The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.J Subst Abuse Treat. 2020 Jan;108:33-39. doi: 10.1016/j.jsat.2019.07.007. Epub 2019 Jul 19. J Subst Abuse Treat. 2020. PMID: 31358328 Free PMC article.
-
Medications for management of opioid use disorder.Am J Health Syst Pharm. 2019 Jul 18;76(15):1097-1103. doi: 10.1093/ajhp/zxz105. Am J Health Syst Pharm. 2019. PMID: 31361869 Review.
-
Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.Harv Rev Psychiatry. 2015 Mar-Apr;23(2):63-75. doi: 10.1097/HRP.0000000000000075. Harv Rev Psychiatry. 2015. PMID: 25747920 Review.
Cited by
-
Expanding access to medication treatment for opioid use disorders: Findings from the Washington State hub and spoke effort.Drug Alcohol Depend. 2024 Mar 1;256:111125. doi: 10.1016/j.drugalcdep.2024.111125. Epub 2024 Feb 14. Drug Alcohol Depend. 2024. PMID: 38368666
-
Statewide efforts to address the opioid epidemic: Results from a national survey of single state agencies.J Subst Use Addict Treat. 2024 May;160:209309. doi: 10.1016/j.josat.2024.209309. Epub 2024 Feb 8. J Subst Use Addict Treat. 2024. PMID: 38336265
-
Linkage facilitation services for opioid use disorder: Taxonomy of facilitation practitioners, goals, and activities.J Subst Use Addict Treat. 2024 Feb;157:209217. doi: 10.1016/j.josat.2023.209217. Epub 2023 Nov 20. J Subst Use Addict Treat. 2024. PMID: 37981242 Review.
-
Lessons Learned from Implementation of a Post-opioid Overdose Outreach Program in a Rural Massachusetts Community.Community Ment Health J. 2024 Apr;60(3):482-493. doi: 10.1007/s10597-023-01198-8. Epub 2023 Oct 30. Community Ment Health J. 2024. PMID: 37902945
-
Availability of best practices for opioid use disorder in jails and related training and resource needs: findings from a national interview study of jails in heavily impacted counties in the U.S.Health Justice. 2022 Dec 20;10(1):36. doi: 10.1186/s40352-022-00197-3. Health Justice. 2022. PMID: 36538121 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous